Legal LSD derivate – a research chemical, each containing X micrograms of high-purity compound. Synthesized under strict laboratory conditions, 1S-LSD is designed exclusively for analytical and research purposes.
Dosage: The individual blotters have a side length of Xmm, and each contains X mcg 1S-LSD.
The manufacturer lists the following ingredients in adition to 1S-LSD: Soy-based ink, 200 gsm blotting paper (all ingredients are not of animal origin).
Manufacturer’s note: Not intended for human consumption. Intended strictly for scientific, forensic, or educational research.
IUPAC:(8β)-1-(3-(trimethylsilyl)propionyl)-N,N-diethyl-6-methyl-9,10-didehydroergoline-8-carboxamide-hemi-D-tartrate
Storage: Cool and dry, away from sunlight – if possible below 20°C.
Chemical formula: C26H37N3O2Si
Molecular mass: 526.7 g mol−1
Manufacturer: X
1S-LSD is a structural analog of LSD and part of the lysergamide family, developed to support advanced neurochemical and analytical research. Its profile offers valuable data for comparison with other derivatives such as 1D-LSD, 1P-LSD, and 1V-LSD.
Legal notice: This product is sold for laboratory and research use only. It is not intended for human consumption or medical use. Please ensure compliance with local laws before ordering.
Delivery
Shipping & Delivery Information
Estimated delivery times:
Germany: 3–7 business days
European Union: 3–7 business days
Outside Europe: Approx. 10–14 business days (depending on destination)
Shipping method:
All orders are shipped discreetly in neutral, padded envelopes
Packaging contains no logos or product references
Every order comes with a tracking number so you can monitor delivery at any time
We process orders quickly and confidentially, ensuring a smooth and secure experience from checkout to delivery.
📌 Please ensure that your shipping address is correct. We are not responsible for delays caused by incorrect or incomplete information.
Reviews
There are no reviews yet.
Be the first to review “150 mcg 1S-LSD” Cancel reply
🔬 1S-LSD – Research Profile and Scientific Overview
1S-LSD is a lysergamide-based compound built on an ergoline backbone, developed as a prodrug of LSD. Like other well-known analogs such as 1P-LSD and 1cP-LSD, 1S-LSD is believed to undergo metabolic conversion into active LSD-25, making it highly relevant in the context of psychedelic research and analytical testing. Pharmacologically, a prodrug is an inactive molecule that becomes active after ingestion due to natural metabolic processes in the body. This mechanism makes 1S-LSD particularly valuable for researchers studying the structure–activity relationship (SAR) and receptor interactions of lysergic compounds — without directly working with controlled substances like LSD-25.
Preliminary research and anecdotal reports indicate that 1S-LSD may produce similar effects to LSD-25 and 1D-LSD, though slight differences in potency, onset, and receptor binding affinity have been observed. These nuances provide fertile ground for scientific exploration, especially in fields such as receptor mapping, neurochemical modeling, and dose-response simulations. Our 1S-LSD blotters and pellets are manufactured using high-purity, research-grade materials under professionally controlled, hygienic laboratory conditions. Each unit is securely packaged in light- and moisture-resistant materials to ensure chemical stability, purity, and safe transport. We are committed to providing reliable, lab-verified research substances that meet the expectations of modern scientific standards.
Please note: 1S-LSD is sold strictly for research and analytical purposes only. It is not intended for human consumption or any form of recreational use. All usage must comply with local legal regulations and be conducted under sound scientific methodology. If you’re looking to buy 1S-LSD for research, visit our official shop page here to order with confidence.
📌 This information is provided for scientific and educational purposes only and does not constitute medical or legal advice.
Quick Onset and Activation
One of the key characteristics of 1S-LSD is its fast onset compared to other LSD analogs. Based on research reports and user data, 1S-LSD typically takes effect within 30 to 60 minutes, which is noticeably faster than 1CP-LSD or LSD-25, both of which often require 60 to 120 minutes for full onset. This faster activation window makes 1S-LSD an efficient candidate for time-sensitive laboratory protocols and short-session experimental models.
Consistency and Reproducibility
Scientific feedback and independent research observations suggest that 1S-LSD offers greater consistency and reproducible results compared to older analogs. Researchers working in microdosing studies or pharmacological screening often prefer 1S-LSD due to its stable profile and predictable outcomes. This makes it especially suitable for controlled lab environments, where precision is crucial and compound variability must be minimized.
Shorter Duration of Action
Reports indicate that 1S-LSD exhibits a shorter active duration than most lysergamides currently in research use. While 1V-LSD already reduced typical session times to around 6–8 hours, 1S-LSD appears to slightly shorten the duration even further, without losing the structural integrity needed for proper testing. In contrast, compounds like 1CP-LSD or LSD-25 may last between 10 to 12 hours, which can be less practical for certain study designs.
Structural Insight and Hypotheses
One possible explanation for 1S-LSD’s rapid onset lies in its unique molecular structure. Researchers speculate that the compound’s 1,2-dimethylcyclobutane group plays a role in accelerating metabolic hydrolysis, allowing it to convert more quickly into active LSD in vivo. This structural trait might contribute to both its quicker onset and shorter half-life, distinguishing it from other LSD analogs used in experimental pharmacology.
Reviews
There are no reviews yet.